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ABSTRACT 
A number of potential candidate genes in a variety of biological pathways have been associated with longevity 
in model organisms. Many of these genes have human homologues and thus have potential to provide 
insights into human longevity. Recently, several studies suggested that FOXO3A functions as a key bridge of 
various signaling pathways that influence aging and longevity. Interestingly, Willcox BJ and colleagues 
identified several variants which displayed significant genotype-gender interaction in male human longevity. In 
particular, a nested case-control study was performed in an ethnic Japanese population in Hawaii and five 
candidate longevity genes were chosen based on links to the insulin-IGF1-signaling pathway. In the Willcox 
study, the investigated genetic variations (rs2802292, rs2764264, and rs13217795) within the FOXO3A gene 
were significantly associated with longevity in male centenarians.  
We validated the association of FOXO3A polymorphisms with extreme longevity in males from the Southern 
Italian Centenarian Study. Particularly, rs2802288, a proxy of rs2802292, showed the best allelic association 
(MAF=0.49, p=0.003, OR=1.51, 95% CI: 1.15-1.98). Furthermore we undertook a meta-analysis in order to 
explore the significance of rs2802292 association with longevity by combining the association results of the 
current study and the findings coming from the Willcox BJ et al. investigation.  
Our data point to a key role of FOXO3A in human longevity and confirm the feasibility of the identification of  
such genes with centenarian-controls studies. Moreover, we hypothesize the susceptibility to the longevity 
phenotype may well be the result of complex interactions involving genes, environmental factors but also 
gender.  
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INTRODUCTION 
Aging is a multifactorial and complex process regulated by stochastic interactions (random damage to vital 
molecules), extrinsic interventions (such as diet and caloric restriction) and intrinsic/genetic alterations. A 
number of centenarian (people aged 100 years old or older) studies exploit the strong selection of favourable 
genotypes in exceptionally aged individuals to study candidate genes and to perform genome wide analyses. 
Replications of observed associations of genotypes with longevity, coupled with functional studies to define 
mechanisms whereby specific genotypes influence lifespan associated phenotypes, are essential to delineate 
true positive genetic findings. Such findings could potentially lead to preventive and therapeutic interventions 
for several age-related diseases that cause significant morbidity and mortality among older people.  
Numerous genes have been identified that are either positively or negatively selected in the centenarian 
population as a consequence of a demographic selection 1, but no consistent replications have been observed 
in independent population, with the exception of Apolipoprotein E (APOE) 2,3. In addition, animal studies have 
provided insights into the types of genes that can be involved in the regulation of lifespan. The first longevity 
mutant to be identified was the C. Elegans gene PAX2 age-1 4 that encodes phosphatidylinositol 3-kinase 
(PI3K) 5, which has a key role in a signalling pathway that is homologous to the mammalian insulin– IGF1 
(insulin-like growth factor 1) pathway. Genetic studies in C. Elegans have demonstrated that activation of the 
PIK3/Akt pathway by IGF1 suppresses activity of DAF-16 forkhead transcription factor, the nematode ortholog 
of mammalian FOXO proteins. FOXO transcription factors belong to the Forkhead family of proteins, a family 
characterized by a conserved DNA binding domain (Forkhead box) for phosphorylation by the survival kinase 
Akt 6. Particularly, in mammals the FOXO subgroup (FOXO1, FOXO3, FOXO4 e FOXO6) promote the 
expression of numerous downstream genes that mediate stress resistance, innate immunity, metabolic 
processes and toxin degradation 7,8.  
A moderate reduction in the intake of calories [also known as caloric restriction (CR)] is extremely effective in 
delaying age-related decline and increasing longevity in organisms ranging from yeast to mammals 9,10. In this 
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regard, Bonkowski and colleagues observed a striking difference in the response of growth hormone (GH) 
receptor/GH-binding protein knockout (GHRKO) and normal mice to an identical regimen of CR 11. When male 
and female longevity data were analyzed separately, it became evident that the effects of CR on maximal 
longevity were sexually dimorphic in GHRKO mice but not in normal mice.  
To be noted, susceptibility to many common diseases, well as longevity, may well be the result of complex 
interactions involving genes, environmental factors and, intriguingly, gender.  
In this scenario, FOXO is a key component of the insulin pathway, free radical  production and human 
longevity.  
In the prospective population based Leiden 85 plus Study (866 females and 379 males, aged 85 years or 
more), the effect of genetic variants in FOXO1A and FOXO3A were analyzed on metabolic profiles, fertility, 
fecundity, age-related diseases (i.e. diabetes, myocardial infarction, etc) and mortality 12. In detail, FOXO3A 
haplotypes showed no association with longevity and other investigated variables. One possible drawback of 
this finding is total absence of gender stratification. In fact, the hormonal environment as well as tissue specific 
gene expression is known to differ significantly between genders in vertebrates. Hormones may differentially 
affect gene expression in somatic tissues, thus leading to the gender specific susceptibility to a complex 
phenotype, as longevity 11. At this regard, Willcox BJ et al. 13 performed a nested case-control study of five 
candidate longevity genes (ADIPOQ, FOXO1A, FOXO3A, SIRT1 and COQ7) with links to the insulin/IGF 
signaling pathway (IIS). This nested case-control study was conducted in an ethnic Japanese population from 
the Island of Oahu (Hawaii) with 213 male longevity “cases” and 402 male “average-lived” controls, and found 
three SNPs associated with the “longevity” phenotype in the locus of FOXO3A gene: rs2764264 (p=0.0002), 
rs13217795 (p=0.0006) and rs2802292 (p<0.0001) 13. The aim of our study was to support the potential role of 
FOXO3A as a key component that influence longevity with a case-control study. In this regard, we screened 
480 long-living “cases” (281 males and 199 females) and 335 young controls (195 males, 140 females) from 
an isolated and homogeneous population of Southern Italy (Southern Italian Centenarian Study-SICS) with 
Illumina BeadChip 300K and we focused on FOXO3A gene. As previously described, we hypothesized that 
gender may influence the association between FOXO3A and longevity; thus we analyzed  males and females 
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 5 
separately. We performed a powerful method for correcting for stratification of our population. Lastly, we 
exploited a meta-analysis approach to pool Willcox’s findings in order to find evidence for statistical 
association for SNP rs2802292. 
 
RESULTS 
We recruited and phenotyped 281 male longevity “cases” (mean age 95 years) and 195 male “controls” (mean 
age 33 years) as part of the SICS. Subsequently, we genotyped these subjects (Table 1) using the Illumina 
300k SNPs mapping BeadChip. 
After a preliminary phase of quality control (see methods section), we looked for evidence of population 
heterogeneity on a set of 258 males centenarians (cases) and 178 males controls by applying the Principal 
Component Analysis (PCA) as implemented in EigenSoft 2.0 package 14. The estimation of the over-dispersion 
of trend test statistics (λ) was 1.05, decreasing to 1.027 after correction for the first 4 significant principal 
components: this indicates a small or null confounding effect of population structure on our association results. 
(Fig.1) 
In order to test for associations between SNPs and the longevity phenotype, we compared allele and genotype 
frequencies between cases and controls by means of allelic and genotypic association tests (Table 2, Table 
S1). Results from all analyses were very similar for significantly associated SNPs whether or not adjustments 
for population structure were applied (Table S2). None of the analyzed SNPs showed deviations from the 
Hardy Weinberg Equilibrium (p-HWD<0.05) or significant differences in missing data fractions between cases 
and controls (p<0.05). All SNPs showed a genotyping call rate > 98.8%. 
We also performed logistic regression analyses assuming an additive model and by comparing homozygous 
minor versus homozygous major alleles on a set of SNPs located on the FOXO3A locus (Table 2). In order to 
confirm the null-influence of population structure on our results we also performed association tests correcting 
along the top 4 principal components by means of logistic regression assuming an additive effect of allele 
dosage on the same SNP set.  
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We first focused on rs2802288, showing Linkage Disequilibrium (LD) with rs2802292 (r2=1) in the HapMap 
CEU data panel 15. Particularly, allelic association tests highlighted significant association for rs2802288 in 
males (MAF=0.49, p=0.003, OR=1.51, 95% CI: 1.15-1.98). Moreover, this association was also confirmed by 
logistic regression under an additive model (p=0.0026, OR=1.53, 95% CI: 1.16-2.03) and by comparing 
homozygous minor versus homozygous major alleles (p=0.0023, OR=2.44, 95% CI: 1.37-4.34). (Table 2) 
 Successively, we imputed missing SNPs by means of Impute 16 software to better represent the 6q21 region. 
Rather, interestingly, the imputed rs2802292 (MAF=0.47) that was previously indicated by Willcox BJ et al. 13 
as the best association, showed r2 =0.79 with rs2802288 (MAF=0.49), similarly to that observed in the Hap-
Map CEU panel 15. In fact, our imputation analysis confirmed that rs2802292, unrepresented on the BeadChip, 
was responsible for the strongest association effect in this region (MAF=0.468, p=0.0028; OR: 1.53; CI 95%: 
1.16-2.03, allelic association test). Additionally,  we confirmed this significant association by logistic regression 
under additive model (p=0.0022; OR: 1.57; CI 95%: 1.17-2.10) and by comparing homozygous minor versus 
homozygous major alleles (p= 0.0019; OR: 2.58; CI 95%: 1.42-4.70). (Table 2) 
To evaluate a possible joint effect of FOXO3A gene and the environmental exposure (such as smoke, etc)  or 
FOXO3A and the non –genetic attributes (such as clinical-cognitive variables), we performed a covariates 
analysis. No significant association of genotypes with  cognitive variables (Barthel score, cognitive score, 
anxiety, depression) or clinical phenotypes (diabetes mellitus, glaucoma, high blood pressure, kidney 
diseases, osteoporosis, smoking history, cancer) was detected. Then, we can hypothesize that FOXO3A have 
an effect on longevity independently of the tested variables. Subsequently, we generated a LD plot with the 
software HaploView v4.0 17. LD blocks are delineated by black lines and defined using the Four Gamete Rule, 
a variant on the algorithm described in previously published study 18, as implemented in HaploView software 
19. 
Using this analysis, multimarker association tests showed a slightly significant association (p= 0.03) for a 24kb 
haplotype (Fig 2, Block 1; Table 3) comprising 3 SNPs carrying the minor allele (A) for rs2802288,and defining 
boundaries of a locus affected by a potential causative mutation for the extreme longevity phenotype. As  can 
be observed in Figure 2, the LD-plot defines a locus that includes  the 5’ untranslated regions and the first 
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 7 
coding region of the investigated gene. Subsequently, in order to confirm the gender-specificity of the 
FOXO3A association, we also studied 199 female longevity “cases” (mean age 98 years) and 140 female 
“controls” (mean age 31 years) drawn from the same population (88% power to detect the association). No 
differences in terms of allele frequencies between centenarians and controls have been detected for 
rs2802288 in female individuals (176 centenarians and 113 controls that pass the quality control filtering 
criteria) (MAF=0.48, p= 0.3975, OR= 0.86, 95% CI: 0.62-1.21) (Table 2). The absence of association in the 
female gender has been further confirmed by logistic regression assuming an additive model (p=0.4034, 
OR=0.87, 95% CI: 0.62-1.21) and by comparing homozygous minor versus homozygous major alleles (p= 
0.4048, OR=0.75, 95% CI: 0.39-1.47) (Table 2). 
Furthermore, we undertook a meta-analysis in order to explore the significance of the rs2802292 association 
with longevity by combining the association results of the current study and the findings coming from the 
Willcox BJ et al. investigation. We combined the logarithm of the OR estimates and 95% CI for homozygous 
minor vs homozygous major alleles from the current analysis (OR=2.44, 95% CI: 1.37-4.34) and from Willcox 
BJ et al. study (OR=2.75, 95% CI: 1.51-5.02)  to obtain a summary OR using fixed 20 and Der Simonian and 
Laird random effects models 21. Fixed effects models assume that the effect of a risk allele has the same value 
in each dataset while random effects models assume that the risk allele effects for each study vary around 
some overall average effect 22. The inconsistency metric I2 23 was 0%, while the Q statistic 24 was not 
statistically significant (p=0.88) indicating a null between-study heterogeneity evidence. Since no evidence of 
between-study heterogeneity have been proven, fixed effects 20 and Der Simonian and Laird random effects 21 
coincide, generating identical summary point estimates (OR= 2.66, 95% CI: 1.74-4.07, p=0.0001) (Fig 3).  
 
DISCUSSION 
Research into ageing has been rejuvenated by the recent discovery of SNPs in candidate genes that can 
extend lifespan of laboratory model organisms. Thus, these polymorphisms can also delay, ameliorate or even 
abolish the impact of many ageing-related diseases, including cardiovascular disease, neurodegeneration and 
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cancer. FOXO transcription factors have been implicated in regulating different cellular functions, such as 
differentiation, metabolism, proliferation, and survival 7,25. 
At this respect, in the Leiden Prospective Study the overall and individual haplotype frequencies were not 
different between the elderly and young control group for the FOXO3A locus 12. However, possible limitations 
of the study is in the absence of gender stratification. In fact, due to the profound effect of this pathway on the 
reproductive/hormonal system, that differs between males and females, it is possible that variants that affect 
genes of this pathway are gender specific enriched/depleted as the populations age. Hence, variants that 
influence longevity in males may not affect female longevity and vice-versa.  
Recently, Willcox BJ and colleagues demonstrated an association with exceptional longevity and FOXO3A 
gene in an ethnic Japanese population in Hawaii, focusing on male individuals only 13.Although there was no 
population stratification, effect observed in this study a possible limitation in most. Stratification is the result of 
imbalance of ethnic background between cases and controls. It is usually modest when the recruitment is 
consistent among cases and controls, and for populations that didn’t suffer of recent immigration. In the 
present study, we extrapolated the FOXO3A locus from our genome wide association data on a part of the 
SICS. Particularly, we genotyped (with BeadChip 300k, Illumina) 281 SIC male nonagenarians and 195 SIC 
male controls. It was encouraging to report the association between rs2802292 at FOXO3A locus and 
longevity phenotype was convincingly and independently confirmed in our SICS homozygous minor versus 
homozygous major alleles (p= 0.0019; OR: 2.58; CI 95%: 1.42-4.70). Moreover, to avoid a possible drawback 
of population structure we demonstrated a small or null confounding effect of population structure on our 
association results, thus excluding type I errors (Fig. 1, Table S2). Our aim was to replicate rs2802292 in male 
longevity, and to explore the FOXO3A locus in males and females to generate eventual new candidate SNPs 
for longevity and to clarify the gender interaction on the FOXO3A locus and longevity. Replication efforts 
require adequate sample size and our male population was sufficient to achieve >90% power to detect an 
allele with  40% allele frequency and a factor of 1.5 effect, as previously reported in Willcox paper for 
rs2802292 26. 
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Meta-analysis represents a well-established method to summarize results and draw conclusions from different 
studies for a set of common hypothesis, therefore we applied this approach in order to combine our 
association results for the SNP rs2802292 with the findings coming from Willcox BJ et al. study and to achieve 
more statistical power. The null-significance of the Q-statistics 24 (p=0.88) and the inconsistency metric 23 
value (I2=0%) confirmed the absence of between-study heterogeneity (Table 4). In absence of heterogeneity 
between the two datasets we obtained identical estimates of the ORs and the 95% CIs for homozygous minor 
vs homozygous major alleles from both fixed 20 and random effects 21 models (OR= 2.66, 95% CI: 1.74-4.07, 
p=0.0001) ( Fig 3). 
To be noted, this is the first convincing replication of an association with longevity after the APOE association 
3.  
As stressed by National Cancer Institute-National Human Genome Research Institute (NCI-NHGRI) Working 
Group on Replication in Association Studies 27, validation of the postulated gene-investigated phenotype 
association in a population different from that of the previous study is of great value.  
It is also established that mitochondrial Sirtuin 3 interacts with and under specific cellular conditions regulates 
the activity of FOXO3A. Additionally, SIRT3 regulates a series of essential intracellular processes that defend 
the cell against multiple types of cellular damage, including oxidative damage 28. A rise in the level of reactive 
oxygen species (ROS) has two important effects: it can damage proteins, lipids, and DNA, leading to cell 
death or it can trigger the activation of specific physiologic signalling pathway 29. Moreover, a GH-IGF1 
pathway has been implicated in determination of longevity in a variety of species 10,30.  
Genetic variants that are either positively or negatively selected as population ages impact on survival ( 
demographic selection). In this regard, FOXO3A gene SNP rs2802292 should have a protective role. 
These observations imply that the FOXO3A gene SNP rs2802292, or SNPs in LD, have a protective role by 
partially increasing the ability of other proteins to activate FOXO3A, or by increasing FOXO3A activity on 
downstream targets. Re-sequencing of the FOXO3A locus will clarify the nature of the genetic variation that is 
tracked by rs2802292. It is possible that the variation does not need to affect coding genes, since coding 
genes from less than one-third of the evolutionary conserved genome 26. Furthermore, future population 
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studies on diseases of aging will clarify if FOXO3A associate across diseases, as for the longevity gene APOE 
and Alzheimer ‘s / cardiovascular diseases.  
To be noted, from the data that we obtained in our population, the association is strictly linked with male-
gender. Taking in consideration these new evidences, we would suggest a gender specific analysis for the 
longevity phenotype. 
To conclude, the discovery and replication of a convincing association of FOXO3A locus contributes to the 
hypothesis that the impact of the IGF-I/insulin pathway on longevity is a property that has been evolutionarily 
conserved throughout the animal kingdom. 
 
MATERIALS and METHODS 
Subject features 
This case/control study was carried on as a part of the Southern Italian Centenarian Study (SICS). The SIC 
study (2002) has assembled a large cohort of 600 DNA samples of nonagenarians/centenarians (age range  
90-109 years) and 800 DNA samples of young controls (age range 18-48 years) from a isolated region of 
Southern Italy east of Naples with a high prevalence of long lived and healthy and characterized by a high 
level of endogamy 31. All participants for the current study was well-characterized, in fact detailed phenotypic 
information about self reported health history, cognitive and physical functions measured through Blessed 
memory tests and Barthel scores of activity of daily living, as well as demographic and exposure to common 
risk factors such as alcohol and smoking were collected. For the aim of the present investigation, 281 long-
lived men (age range 90-108 years) and 195 controls (age range 18-48 years) were genotyped (Table 1).  
The subjects were enrolled by an Italian subsidiary (Associazione Longevità) of Elixir Pharmaceuticals (former 
Centagenetix Inc). All subjects donated blood samples for DNA study and gave written informed consent to the 
study. The study was conducted in accordance with the ethical principles that have their origins in the 
Declaration of Helsinki.  
Genotyping: Illumina BeadChip 
Formatted: Highlight
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Genotyping was carried out using the Infinium II Assay-HumanHap BeadChip 317K-duo (Illumina) using 
standard protocol. In fact, Illumina's Infinium II Whole-Genome Genotyping Assay is designed to interrogate a 
large number of single nucleotide polymorphisms (SNPs) at unlimited levels of loci multiplexing. HumanHap 
317-Duo workflow can be divided in three main segments: (1) sample preparation, (2) sample fragmentation 
and hybridization, (3) extension, staining, and scanning.  
The BeadChps are imaged using a two-color confocal laser system with 0.8-µm resolution. The bead 
intensities are extracted, and genotypes are calculated using an Illumina-supplied cluster file, which is based 
on a set of reference samples. The normalization algorithm adjusts for nominal offset, cross-talk, and intensity 
variations observed in the two-color channels.The data for each BeadChip is self-normalized using information 
contained within the array. This normalization algorithm removes outliers, adjusts for channel-dependent 
background and global intensity differences, and also scales the data. The X and Y color channels undergo an 
affine coordinate transformation to make the data appear as canonical as possible with the homozygotes lying 
along the transformed x- and y-axes. All genotypes will be evaluated using a quantitative quality score called 
GenCall score. A GenCall score ranges from 0 to 1 and reflects the proximity within a cluster plot of the 
intensities of that genotype to the centroid of the nearest cluster.  
Statistical analysis  
Quality control: Individuals showing genotyping rate <93% and SNPs with genotyping rate <95% have been 
excluded from the dataset. We screened for contaminations and evaluated relationships among individuals 
using Identity By Descent (IBD) estimations: samples showing extreme heterozygosis and related individuals 
have been removed. X chromosome data have been used to check for the discordances in terms of gender 
assignment. SNPs with MAF < 0.01 and markers deviating from the Hardy Weinberg Equilibrium (HWE) in the 
control population (p-HWD < 0.001) have been excluded from the analysis. 
Population structure: In order to assess  the absence of population stratification we applied the Principal 
Component Analysis (PCA) approach, a method that can capture subtle and extensive variations due to both 
ethnical, experimental and technical features 14. All autosomal SNPs and individuals that passed the quality 
control filters (299772 SNPs, 258 centenarians, 178 controls) have been used as input to the EigenSoft 2.0 14 
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software using the default parameters except for the number of outliers removal iterations that was set to 0 to 
obtain estimate for all subjects.  
Imputation: To impute SNPs from multimarker tags we used Impute v0.5.0 16.  
Association tests: We evaluated the association of markers with longevity phenotype by means of allelic 
association tests (1d.f.) and applied Pearson χ2 test (2 d.f.) and Fisher exact test (if cell counts were < 5) in 
order to compare genotype frequencies between cases and controls. We also performed logistic regression 
under an additive model and logistic regression comparing homozygous minor vs homozygous major alleles. 
Correction for population stratification have been performed using logistic regression under additive model 
adjusting along the top 4 statistical significant principal components. Allele frequencies, genotype counts, OR 
and 95% confidence intervals (95% CI) have been also estimated for each SNP. 
Meta-analysis: We used the OR and 95% CI for homozygous minor vs homozygous major alleles from the 
current analysis and from Willcox BJ et al. study to calculate the natural logarithms of the OR (Log-OR) and its 
standard error (SE). The Log-OR estimates were combined to obtain a summary OR following fixed 20 and Der 
Simonian and Laird random effects 21 models using inverse variance calculations. Between dataset 
heterogeneity was identified using the I2 metric for inconsistency 23 and its statistical significance was 
assessed by means of the χ2 distributed Q statistic 24 (the number of d.f. is given by k-1, where k is the number 
of analyzed datasets). All calculations have been performed using R v2.7.1 software. 
Haplotype analyses: We used HaploView 4.0 17 for blocks definition, haplotypes estimation and association 
tests. We defined haplotype blocks using the Four Gamete Rule, a variant on the algorithm described in Wang 
study 18 and estimated haplotypes using the default accelerated EM algorithm 17. Differences in haplotype 
frequencies between centenarians and controls have been tested by means of χ2 tests, excluding from the 
analysis haplotypes with a frequency < 0.01. 
Covariate analyses: Associations between clinical risk factors, cognitive variables with genotypes have been 
tested among nonagenarians by means of logistic and linear regression using R v2.7.1 software 
(http://www.R-project.org).  
All statistical analyses have been performed using PLINK v1.04 32 software except when specified. 
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Table 2: FOXO3A locus in long-living individuals and controls. 
Table 3: Haplotype association test of block 1 using HaploView.  
 
FIGURE LEGENDS: 
 
Figure 1. Population structure of centenarians (red) and control subjects (black). Each scatter plot 
shows the first two principal components that were estimated using genotype data for more than 300K SNPs 
in centenarians and control subjects using the program EigenSoft 2.0. The two populations are ethnically 
identical as shown in the right scatter plot. 
 
Figure 2. Pattern of LD of FOXO3A region displayed using D’ with HaploView. LD displays were 
generated using the D’ colour scheme. The different shades of red indicate different D’ value (0<D’<1). 
Haplotype blocks were generated using the Four Gamete Rule as implemented in HaploView software. Boxed 
in green is rs2802288, boxed in blue are the SNPs explored by Willcox BJ et al. 
 
Figure 3. Meta-analysis of rs2802292 variant in the current investigation and in Willcox study.  
Each study is represented by the estimate of the homozygous minor vs homozygous major alleles OR and its 
95% CI (circle). Summary effects by random effects (rhombus) and fixed effects (rectangle) calculations are 
also shown. 
Deleted: male 
Deleted: Table 4: Meta-analysis for 
rs2802292 combining Okinawa study and 
SICS.¶
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Table 1 : Age (years) distribution by gender and by centenarian/control phenotype 
 
  Males Females 
Phenotype n Mean ±SD Min-Max n Mean ±SD Min-Max 
Centenarians  281 94.96 ± 2.97 90-108 199 98.05 ± 3.25 90-109 
Controls  195 33.53 ± 7.33 18-48 140 31.39 ± 7.31 18-48 
 
Footnote: n= number of individuals; SD= standard deviation; Min= minimum age; M= Maximum age 
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Table 2: FOXO3A locus in long-living individuals and controls 
MAF Allelic Additive Homozygous 
SNP 
gender 
Overall Cases Controls OR (95%CI) p OR (95%CI) p OR (95% CI) p 
M 0.2 0.22 0.18 1.27(0.90-1.80) 0.1659 1.30 (0.91-1.85) 0.1524 0.92 (0.30-2.80) 0.8786 
rs9486902 
F 0.23 0.21 0.27 0.69 (0.47-1.02) 0.0634 0.67 (0.45-1.01) 0.0553 0.52 (0.16-1.70) 0.2800 
M 0.49 0.53 0.43 1.51 (1.15-1.98) 0.003 1.53 (1.16-2.03) 0.0026 2.44 (1.38-4.34) 0.0023 
rs2802288 
F 0.48 0.47 0.5 0.86 (0.62-1.21) 0.3975 0.87 (0.62-1.21) 0.4034 0.75 (0.39-1.47) 0.4048 
M 0.12 0.14 0.1 1.57 (1.02-2.41) 0.04 1.56 (1.01-2.41) 0.0409 NA 0.9982 
rs10499051 
F 0.12 0.11 0.12 0.95 (0.57-1.60) 0.8497 0.95 (0.56-1.61) 0.8474 0.32 (0.03-3.62) 0.3598 
M 0.47 0.51 0.41 1.53 (1.16-2.03) 0.0028 1.57 (1.17-2.10) 0.0022 2.58 (1.42-4.70) 0.0019 
rs2802292*  
F NA NA NA NA NA NA NA NA NA 
M 0.2 0.18 0.22 0.79 (0.563-1.11) 0.1682 0.79 (0.56-1.10) 0.1653 0.80 (0.29-2.20) 0.6619 
rs13220810 
F 0.22 0.23 0.2 1.17 (0.78-1.77) 0.4482 1.17 (0.78-1.78) 0.4471 1.12 (0.35-3.57) 0.8441 
M 0.4 0.43 0.36 1.37 (1.04-1.81) 0.0267 1.40 (1.05-1.86) 0.0227 1.99 (1.07-3.70) 0.0285 
rs2764264  
F 0.41 0.4 0.42 0.93 (0.66-1.30) 0.6575 0.92 (0.65-1.31) 0.6553 1.03 (0.49-2.18) 0.9312 
M 0.17 0.17 0.15 1.16 (0.80-1.67) 0.4364 1.15 (0.80-1.64) 0.4512 2.14 (0.67-6.79) 0.1963 
rs7341233 
F 0.14 0.16 0.12 1.51 (0.92-2.48) 0.1047 1.51 (0.92-2.49) 0.1070 3.61 (0.41-31.41) 0.2454 
M 0.15 0.15 0.15 1.05 (0.71-1.53) 0.8172 1.04 (0.72-1.50) 0.8237 1.72 (0.53-5.60) 0.3683 
rs17598747 
F 0.12 0.13 0.1 1.44 (0.84-2.46) 0.1825 1.43 (0.84-2.43) 0.1911 2.79 (0.31-25.35) 0.3626 
M 0.22 0.24 0.2 1.29 (0.93-1.80) 0.1274 1.34 (0.94-1.90) 0.1054 1.76 (0.53-5.88) 0.3561 
rs9285397 
F 0.26 0.24 0.31 0.71 (0.49-1.03) 0.0699 0.69 (0.47-1.02) 0.0637 0.71 (0.26-1.99) 0.5190 
M 0.15 0.15 0.15 1.07 (0.73-1.56) 0.739 1.06 (0.74-1.53) 0.7479 1.74 (0.53-5.60) 0.359 
rs12202209 
F 0.12 0.13 0.1 1.44 (0.84-2.46) 0.1825 1.43 (0.84-2.43) 0.1911 2.79 (0.31-25.35) 0.3626 
M 0.21 0.22 0.19 1.24 (0.87 1.75) 0.206 1.27 (0.89-1.80) 0.1881 1.71 (0.52-5.71) 0.3781 
rs9480866 
F 0.24 0.21 0.29 0.67 (0.46-0.99) 0.0412 0.65 (0.44-0.97) 0.0370 0.51 (0.17-1.53) 0.2279 
M 0.15 0.15 0.15 1.06 (0.72 1.54) 0.7751 1.05 (0.73-1.52) 0.7829 1.72 (0.53-5.60) 0.3683 
rs12207868 
F 0.12 0.13 0.1 1.43 (0.84-2.44) 0.1905 1.42 (0.83-2.41) 0.1992 2.77 (0.30-25.16) 0.3662 
M 0.35 0.38 0.3 1.42 (1.06 1.90) 0.0176 1.44 (1.07-1.945) 0.0159 2.30 (1.14-4.64) 0.0196 
rs13217795*  
F NA NA NA NA NA NA NA NA NA 
F 0.4 0.38 0.42 0.83 (0.59-1.18) 0.3009 0.83 (0.59-1.18) 0.2979 0.83 (0.39-1.73) 0.6107 
rs2153960 
M 0.38 0.41 0.34 1.31 (0.99 1.74) 0.0578 1.33 (1-1.78) 0.0521 1.87 (0.99-3.53) 0.0542 
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M 0.36 0.38 0.33 1.25 (0.94 1.67) 0.1187 1.26 (0.94-1.68) 0.1162 1.65 (0.87-3.12) 0.1222 
rs3800229 
F 0.38 0.36 0.41 0.81 (0.57-1.14) 0.2285 0.81 (0.57-1.15) 0.2310 0.75 (0.36-1.58) 0.4478 
M 0.36 0.38 0.33 1.25 (0.94 1.67) 0.118 1.26 (0.95-1.68) 0.1143 1.65 (0.87-3.12) 0.1222 
rs1935949 
F 0.38 0.36 0.41 0.81 (0.57-1.14) 0.2200 0.81 (0.57-1.14) 0.2222 0.77 (0.37-1.62) 0.4911 
 
 
Footnotes: Gender = Gender-specific analysis (M = males, F = females),  MAF Overall = minor allele frequency based on whole 
sample, MAF Cases = minor allele frequency in centenarians, MAF Controls = minor allele frequency in the control population; Odds 
Ratio (OR), 95% confidence intervals (95% C.I.) and p-value (p) respectively for allelic association test (Allelic), logistic regression 
under additive model (Additive) and logistic regression comparing homozygous minor (mm) vs homozygous major alleles (MM) 
(Homozygous); * = imputed SNPs;  = SNPs explored by Willcox BJ et al. 
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Table 3: Haplotype association test of block 1 using HaploView.  
Block 1 Gender Frequency Freq Cases Freq Controls p-value 
M 0.51 0.48 0.57 0.003 
CGA 
F 0.51 0.53 0.49 0.3683 
M 0.2 0.21 0.17 0.1588 
TAA 
F 0.23 0.21 0.27 0.0634 
M 0.17 0.18 0.16 0.4968 
CAA 
F 0.13 0.15 0.11 0.2556 
M 0.12 0.14 0.09 0.0381 
CAG 
F 0.12 0.11 0.12 0.8689 
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